June 4, 2015Open Access

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

Key Points

Key points are not available for this paper at this time.

Abstract

When added to statin therapy, ezetimibe resulted in incremental lowering of LDL cholesterol levels and improved cardiovascular outcomes. Moreover, lowering LDL cholesterol to levels below previous targets provided additional benefit. (Funded by Merck; IMPROVE-IT ClinicalTrials.gov number, NCT00202878.).

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Christopher P. Cannon

Political Research Associates

Michael A. Blazing

Brigham and Women's Hospital

Robert P. Giugliano

Clinical Research Institute

Journals

New England Journal of Medicine

Actions

Institutions

Harvard University

Brigham and Women's Hospital

Leiden University Medical Center

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider

Also consider